ATYR vs CLOV · rev $235.0K vs rev $1.37B
aTyr Pharma, Inc. (ATYR) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
aTyr Pharma, Inc. (ATYR) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ATYR revenue for 2024-12-31 was $235.0K. Net income was -$64.0M. Revenue was down 33.4% from 2023-12-31 to 2024-12-31. ATYR currently screens at market cap $471.7M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ATYR currently screens at market cap $471.7M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ATYR and CLOV stock pages for the full models.
Not investment advice.